AR090022A1 - MEDICINES ADMINISTRATION SYSTEM BY ALGINATE TUBE AND METHOD TO THAT EFFECT - Google Patents
MEDICINES ADMINISTRATION SYSTEM BY ALGINATE TUBE AND METHOD TO THAT EFFECTInfo
- Publication number
- AR090022A1 AR090022A1 ARP120102561A AR090022A1 AR 090022 A1 AR090022 A1 AR 090022A1 AR P120102561 A ARP120102561 A AR P120102561A AR 090022 A1 AR090022 A1 AR 090022A1
- Authority
- AR
- Argentina
- Prior art keywords
- tube
- alginate
- medication
- substrate
- administration system
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Sistema de administración de medicamentos por tubo de alginato y el uso del sistema para administrar un medicamento a un sujeto. Uso del sistema de administración de medicamentos por tubo de alginato para el tratamiento de una enfermedad o un desorden o una dolencia en un sujeto y para fines profilácticos. Método de elaboración de un sistema de administración de medicamentos por tubo de alginato. Reivindicación 1: Un sistema de administración de medicamento de retención gástrica y liberación controlada que comprende por lo menos un tubo que tiene una o más capas de alginato y un medicamento terapéutico. Reivindicación 10: Un método para elaborar un tubo de alginato para un sistema de administración de medicamento, que comprende las etapas de: a) revestir un sustrato con un gel de alginato; b) reaccionar el sustrato revestido con una sal; c) secar el sustrato revestido; y d) remover el revestimiento del sustrato por el cual el revestimiento forma un cuerpo administrador de medicamento.Medication tube administration system and the use of the system to administer a medication to a subject. Use of the administration system of medications by alginate tube for the treatment of a disease or disorder or a medical condition in a subject and for prophylactic purposes. Method of elaboration of a system of administration of medications by alginate tube. Claim 1: A gastric retention and controlled release drug delivery system comprising at least one tube having one or more layers of alginate and a therapeutic medicament. Claim 10: A method of making an alginate tube for a medicament delivery system, comprising the steps of: a) coating a substrate with an alginate gel; b) react the coated substrate with a salt; c) drying the coated substrate; and d) remove the coating from the substrate by which the coating forms a medication manager body.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP120102561 AR090022A1 (en) | 2012-07-13 | 2012-07-13 | MEDICINES ADMINISTRATION SYSTEM BY ALGINATE TUBE AND METHOD TO THAT EFFECT |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP120102561 AR090022A1 (en) | 2012-07-13 | 2012-07-13 | MEDICINES ADMINISTRATION SYSTEM BY ALGINATE TUBE AND METHOD TO THAT EFFECT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR090022A1 true AR090022A1 (en) | 2014-10-15 |
Family
ID=51847110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120102561 AR090022A1 (en) | 2012-07-13 | 2012-07-13 | MEDICINES ADMINISTRATION SYSTEM BY ALGINATE TUBE AND METHOD TO THAT EFFECT |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR090022A1 (en) |
-
2012
- 2012-07-13 AR ARP120102561 patent/AR090022A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2017091749A8 (en) | Shape changing drug delivery devices and methods | |
| MX2019006823A (en) | Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor released using an ingestible device. | |
| CY1122143T1 (en) | DRUG COMBINATIONS COMPRISING A B-RAF INHIBITOR, AN EGFR INHIBITOR, AND OPTIONALLY A PI3K-ALPHA INHIBITOR | |
| JP2014111603A5 (en) | ||
| BR112015022465A2 (en) | Non-toxic treatment method for drug withdrawal syndrome | |
| MX2016008362A (en) | Pharmaceutical combinations. | |
| EP4233902A3 (en) | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor | |
| IL233693A (en) | Transmucosal administration system for a pharmaceutical drug and such a system for use in the treatment of a mitochondrial disease | |
| WO2016090024A3 (en) | Combination therapy for treatment of cancer | |
| MX2016011333A (en) | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine. | |
| CO2016003340A2 (en) | Pharmaceutical formulations, processes for preparation and methods of use | |
| CR20150637A (en) | TREATMENT OF MIOPATIC AND NEURODEGENERATIVE DISEASES BY PROTEIN AGGREGATION THROUGH PARENTERAL ADMINISTRATION | |
| PH12018502738A1 (en) | Compositions, devices, and methods for the treatment of alcohol use disorder | |
| WO2014036556A3 (en) | Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine | |
| MX2018001499A (en) | Liquid polymer delivery system for extended administration of drugs. | |
| CR20140358A (en) | DRUG ADMINISTRATION SYSTEM | |
| BR112013029199A2 (en) | drug delivery system, two drug delivery device, method for preparing the same, tablet for sublingual administration of an active ingredient, and method for administering an active ingredient to an individual | |
| MX2017008000A (en) | Single use injection system. | |
| MX2017002897A (en) | Semi-solid chewable dosage form for over-the-counter medications and methods for producing same. | |
| EA201600387A1 (en) | DISPERSE SYSTEM FOR DELIVERY OF MEDICINE SUBSTANCE | |
| UA115250C2 (en) | Pharmaceutical combinations | |
| BR112017022984A2 (en) | device for facilitating the positioning of a catheter to deliver a drug to a spontaneously breathing patient | |
| Maldonado et al. | Update on Emerging Infections: news from the Centers for Disease Control and Prevention. Update to the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections | |
| AR090022A1 (en) | MEDICINES ADMINISTRATION SYSTEM BY ALGINATE TUBE AND METHOD TO THAT EFFECT | |
| CO2018010142A2 (en) | Mesalazine solid formula preparation process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |